trending Market Intelligence /marketintelligence/en/news-insights/trending/RaVUV7jARaYWZ-m34SKYpg2 content esgSubNav
In This List

Becton Dickinson, Bard deal gets conditional nod from EU regulator

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Becton Dickinson, Bard deal gets conditional nod from EU regulator

The European Commission granted conditional approval to Becton Dickinson and Co.'s $24 billion acquisition of C. R. Bard Inc.

As part of the clearance, Becton Dickinson must divest its core needle biopsy devices business and tissue marker product line.

Closing of the deal is expected to occur in the fourth calendar quarter of 2017, subject to customary closing conditions and additional regulatory approvals, including the U.S. Federal Trade Commission and other regulatory bodies.